Elekta issues a SEK 1.5 billion bond and signs a revolving credit facility of SEK 1 billion

• SEK 250 million in the first tranche has a coupon rate of STIBOR 3 months plus a margin of 1.05%
• SEK 500 million in the second tranche has a coupon rate of STIBOR 3 months plus a margin of 1.5%
• SEK 750 million in the third tranche has a coupon rate of STIBOR 3 months plus a margin of 1.95%

All coupon interest payments are made quarterly. Final terms of the bonds are available on Elekta’s website www.elekta.com.

Skandinaviska Enskilda Banken (SEB) and Danske Bank acted as lead manager for the issue.

Elekta has signed an unsecured revolving credit facility of SEK 1 billion with a maturity date in September 2026, with an option to extend for an additional year upon the lenders’ approval. The facility further strengthens Elekta’s financial flexibility and liquidity profile.

The credit facility is provided by Danske Bank and Skandinaviska Enskilda Banken (SEB).

# # #

For further information, please contact:
Peter Nyquist, Head of Investor Relations
Tel: +46 70 424 6127, e-post: [email protected]

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on “X”, formerly known as Twitter.